Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 11/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | GNG2 | P59768 | 1/20 | 0.32 |
| ▸ | GNB1 | P62873 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21665617 | 0.91 | MEN1 (0.49) | PDK2MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL22448035 | 0.90 | SMN1; SMN2 (0.40) | PDK2MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL15832135 | 0.90 | TSHR (0.41) | PDK2MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL18647780 | 0.90 | PDK2 (0.40) | PDK2MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL20182039 | 0.90 | PDK2 (0.40) | PDK2MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL15250328 | 0.90 | PDK2 (0.41) | PDK2MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL17986722 | 0.90 | FABP4 (0.45) | PDK2MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL15250356 | 0.89 | MEN1 (0.46) | PDK2MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL24794243 | 0.88 | HSD17B10 (0.46) | PDK2MAPTKDM4ECYP1A2MAPK1 | |
| SCHEMBL21615073 | 0.88 | CYP1A2 (0.38) | PDK2MAPTSMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200039993-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD (KR) | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200039993-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR | OR51E2, WEE1, WEE2 | PDK2 1472/4885MAPT 1524/4885SMN1; SMN2 2465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.